Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
NCOA4-RET fusion
i
Other names:
NCOA4, Nuclear Receptor Coactivator 4, Androgen Receptor-Associated Protein Of 70 KDa, 70 KDa Androgen Receptor Coactivator, RET-Activating Gene ELE1, 70 KDa AR-Activator, NCoA-4, ARA70, ELE1, RFG, Androgen Receptor Coactivator 70 KDa Protein, Ret-Activating Protein ELE1, Ret Fused, PTC3, RET, Ret Proto-Oncogene, Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret, Cadherin-Related Family Member 16, Rearranged During Transfection, RET Receptor Tyrosine Kinase, Cadherin Family Member 12, Proto-On
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
5979
;
8031
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
RET mutation (20)
RET M918T (12)
RET rearrangement (11)
RET C634W (9)
RET-PTC1 rearrangement (8)
RET C634R (4)
RET C634Y (2)
RET G810C (2)
RET G810D (2)
RET G810R (2)
RET G810S (2)
RET G810V (2)
RET L629P (2)
RET V804L (2)
RET V804M (2)
BRAF V600E + TERT E441del + RET N579K + EZH2 D154E + CDK4 S259L (1)
RET C618R (1)
RET C620R (1)
RET C634* (1)
RET C634F (1)
RET D631_R635delinsG (1)
RET M918T + ATM L804fs*4 + ATM S978fs*12 (1)
RET V637R (1)
RET V804* (1)
RET V804M + M918T (1)
RET V804M + RET M918T + RET G810 + RET Y806 (1)
RET Y900_S904delinsP (1)
RET wild-type (1)
NOTCH2 mutation + NCOA4 mutation + PTEN mutation + EPHA3 mutation + KMT2D mutation (1)
RET mutation (20)
RET M918T (12)
RET rearrangement (11)
RET C634W (9)
RET-PTC1 rearrangement (8)
RET C634R (4)
RET C634Y (2)
RET G810C (2)
RET G810D (2)
RET G810R (2)
RET G810S (2)
RET G810V (2)
RET L629P (2)
RET V804L (2)
RET V804M (2)
BRAF V600E + TERT E441del + RET N579K + EZH2 D154E + CDK4 S259L (1)
RET C618R (1)
RET C620R (1)
RET C634* (1)
RET C634F (1)
RET D631_R635delinsG (1)
RET M918T + ATM L804fs*4 + ATM S978fs*12 (1)
RET V637R (1)
RET V804* (1)
RET V804M + M918T (1)
RET V804M + RET M918T + RET G810 + RET Y806 (1)
RET Y900_S904delinsP (1)
RET wild-type (1)
NOTCH2 mutation + NCOA4 mutation + PTEN mutation + EPHA3 mutation + KMT2D mutation (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
NCOA4-RET fusion
Thyroid Gland Papillary Carcinoma
NCOA4-RET fusion
Thyroid Gland Papillary Carcinoma
lenvatinib
Sensitive: C4 – Case Studies
lenvatinib
Sensitive
:
C4
lenvatinib
Sensitive: C4 – Case Studies
lenvatinib
Sensitive
:
C4
NCOA4-RET fusion
Thyroid Gland Carcinoma
NCOA4-RET fusion
Thyroid Gland Carcinoma
pralsetinib
Sensitive: C4 – Case Studies
pralsetinib
Sensitive
:
C4
pralsetinib
Sensitive: C4 – Case Studies
pralsetinib
Sensitive
:
C4
NCOA4-RET fusion
Cholangiocarcinoma
NCOA4-RET fusion
Cholangiocarcinoma
pralsetinib
Sensitive: C4 – Case Studies
pralsetinib
Sensitive
:
C4
pralsetinib
Sensitive: C4 – Case Studies
pralsetinib
Sensitive
:
C4
NCOA4-RET fusion
Thyroid Gland Papillary Carcinoma
NCOA4-RET fusion
Thyroid Gland Papillary Carcinoma
selpercatinib
Sensitive: C4 – Case Studies
selpercatinib
Sensitive
:
C4
selpercatinib
Sensitive: C4 – Case Studies
selpercatinib
Sensitive
:
C4
NCOA4-RET fusion
Non Small Cell Lung Cancer
NCOA4-RET fusion
Non Small Cell Lung Cancer
RXDX-105
Sensitive: D – Preclinical
RXDX-105
Sensitive
:
D
RXDX-105
Sensitive: D – Preclinical
RXDX-105
Sensitive
:
D
NCOA4-RET fusion
Ovarian Cancer
NCOA4-RET fusion
Ovarian Cancer
FHND5071
Sensitive: D – Preclinical
FHND5071
Sensitive
:
D
FHND5071
Sensitive: D – Preclinical
FHND5071
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.